Skip to main content
NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%

About Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. (AVTX) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for AVTX on iGotFomo.

AVTX Key Statistics

0
AVTX key financial statistics
Current Price$16.29Market Cap$862 million
Daily Change+0.12%Volume644K
52-Week High$24.2752-Week Low$3.43
SectorHealthcareIndustryBiotechnology

Frequently Asked Questions About AVTX

What is Avalo Therapeutics, Inc. (AVTX)?
Avalo Therapeutics, Inc. (AVTX) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
What is the current AVTX stock price?
As of the latest trading session, AVTX trades at $16.29 per share, with a daily change of +0.12%.
What is AVTX's market capitalization?
Avalo Therapeutics, Inc. has a market capitalization of $862 million, making it a small-cap stock.
What sector does AVTX belong to?
Avalo Therapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.